Literature DB >> 26136957

Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma.

Honghai Zhu1, Xiaoyuan Zhu2, Genyang Cheng3, Minghui Zhou1, Weihua Lou2.   

Abstract

Radioresistance severely restricts the clinical treatment of nasopharyngeal carcinoma (NPC). microRNAs (miRs) have been demonstrated to affect cancer progression and radiosensitivity. Thus, the aim of the present study was to identify miRs associated with radioresistance in NPC. A radioresistant NPC cell line (CNE-2-1) was established by continuously exposing CNE-2 cells to radiation. Subsequently, high-throughput sequencing technology was used to detect the regulation of miRs in radioresistant CNE-2-1 cells, and it was observed that miR-21 was among the three most upregulated miRs in CNE-2-1 cells. Therefore, the expression levels of miR-21 were quantified using reverse transcription-quantitative polymerase chain reaction. Finally, the function of miR-21 was investigated by downregulating the expression in the CNE-2-1 cells. The results indicated that the expression of miR-21 was significantly increased in the CNE-2-1 cells, as compared with the CNE-2 cells. In addition, downregulation of miR-21 resulted in enhanced radiosensitivity in the CNE-2-1 cells, as demonstrated by the inhibition in cell viability of these radioresistant cells. Further analysis indicated that miR-21 was able to inhibit the proliferation of CNE-2-1 cells at the G1 phase of the cell cycle. Therefore, these results indicated that miR-21 was able to regulate radioresistance in NPC cells; however, further studies are required to confirm this hypothesis.

Entities:  

Keywords:  microRNA-21; nasopharyngeal carcinoma; radioresistance

Year:  2015        PMID: 26136957      PMCID: PMC4473658          DOI: 10.3892/etm.2015.2403

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  MicroRNAs direct rapid deadenylation of mRNA.

Authors:  Ligang Wu; Jihua Fan; Joel G Belasco
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-22       Impact factor: 11.205

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.

Authors:  Hongping Xia; Samuel S Ng; Songshan Jiang; William K C Cheung; Johnny Sze; Xiu-Wu Bian; Hsiang-Fu Kung; Marie C Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-11-24       Impact factor: 3.575

4.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 6.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

7.  MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Authors:  Cinzia Sevignani; George A Calin; Stephanie C Nnadi; Masayoshi Shimizu; Ramana V Davuluri; Terry Hyslop; Peter Demant; Carlo M Croce; Linda D Siracusa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  12 in total

Review 1.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

2.  MicroRNA-21 depletion by CRISPR/Cas9 in CNE2 nasopharyngeal cells hinders proliferation and induces apoptosis by targeting the PI3K/AKT/MOTOR signaling pathway.

Authors:  Zhenzhou Xiao; Yan Chen; Zhaolei Cui
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

3.  Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.

Authors:  Lei Zhou; Hong-Min Chen; Song Qu; Ling Li; Wei Zhao; Zhong-Guo Liang; Bin-Bin Yu; Kai-Hua Chen; Qi-Teng Lu; Guo-Xiang Lin; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-12-14

Review 4.  MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.

Authors:  Parwez Ahmad; Jiri Sana; Marek Slavik; Pavel Slampa; Pavel Smilek; Ondrej Slaby
Journal:  Dis Markers       Date:  2017-02-23       Impact factor: 3.434

5.  microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma.

Authors:  Ke Cao; Jingjing Li; Jia Chen; Li Qian; Aijun Wang; Xiang Chen; Wei Xiong; Jintian Tang; Shijie Tang; Yong Chen; Yao Chen; Yan Cheng; Jianda Zhou
Journal:  Oncotarget       Date:  2017-07-05

Review 6.  Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors:  Alexandra Iulia Irimie-Aghiorghiesei; Cecilia Pop-Bica; Sebastian Pintea; Cornelia Braicu; Roxana Cojocneanu; Alina-Andreea Zimța; Diana Gulei; Ondřej Slabý; Ioana Berindan-Neagoe
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

7.  Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.

Authors:  Kaihua Chen; Ling Li; Song Qu; Xinbin Pan; Yongchu Sun; Fangzhu Wan; Binbin Yu; Lei Zhou; Xiaodong Zhu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

8.  Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

Authors:  Huan Lin; Ze-Tan Chen; Xiao-Dong Zhu; Ling Li; Song Qu; Zhao Wei; Fang Su; Jing-Ni Wei; Zhong-Guo Liang; Qi-Yan Mo; Jiang-Bo Wu; Hui-Ling Meng
Journal:  Oncotarget       Date:  2017-03-21

9.  Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer.

Authors:  J L Hu; G Y He; X L Lan; Z C Zeng; J Guan; Y Ding; X L Qian; W T Liao; Y Q Ding; L Liang
Journal:  Oncogenesis       Date:  2018-02-20       Impact factor: 7.485

10.  Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.

Authors:  Kai-Hua Chen; Ya Guo; Ling Li; Song Qu; Wei Zhao; Qi-Teng Lu; Qi-Yan Mo; Bin-Bin Yu; Lei Zhou; Guo-Xiang Lin; Yong-Chu Sun; Xiao-Dong Zhu
Journal:  Cancer Med       Date:  2018-08-13       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.